Tibes, Raoul <br/><br/>
The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia.  [electronic resource] 

 -  Journal of hematology & oncology  Oct 2015 
 - 114 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-015-0211-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Aged, 80 and over<br/>Anilides--pharmacology<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Azacitidine--pharmacology<br/>Biphenyl Compounds--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Chromosomes, Human, Pair 5--genetics<br/>Chromosomes, Human, Pair 7--genetics<br/>Drug Synergism<br/>Female<br/>HL-60 Cells<br/>Hedgehog Proteins--genetics<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Myelodysplastic Syndromes--drug therapy<br/>Pyridines--pharmacology<br/>RNA Interference<br/>Signal Transduction--drug effects